1.Advances in research on eukaryotic elongation factor 2 as a potential target for rapid-acting antidepressants
Hairan FAN ; Rong WANG ; Hao WANG ; Xiaolong HU
Journal of China Pharmaceutical University 2026;57(5):692-700
Rapid-acting antidepressants (RAADs) can alleviate depressive symptoms within hours and provide a new therapeutic strategy for major depressive disorder, particularly treatment-resistant depression. Representative RAADs such as ketamine and esketamine exert their rapid antidepressant effects mainly by restoring glutamatergic/GABAergic balance, enhancing AMPA receptor-related signaling, activating the BDNF-TrkB-mTORC1 pathway, and promoting synaptic plasticity. In recent years, the eukaryotic elongation factor 2 kinase (eEF2K)/eukaryotic elongation factor 2 (eEF2) axis has attracted increasing attention as a key molecular link between receptor signaling and translational elongation. Previous studies have mainly focused on the canonical model in which inhibition of eEF2K and dephosphorylation of eEF2 relieve translational repression. However, this model does not fully account for the shared features of different RAADs in translational selectivity, spatiotemporal specificity, and multi-pathway integration. An eEF2-centric analytical perspective is proposed based on current clinical and mechanistic advances in RAAD research, with emphasis on the potential roles of eEF2 in local translational regulation, brain-region-specific plasticity, and multi-pathway integration. In combination with our group’s preliminary work, the potential research value of eEF2 as an intervention node for rapid-acting antidepressants is further discussed. Direct experimental evidence involving eEF2 remains mainly confined to the NMDAR/eEF2K/eEF2 pathway and to animal and cellular studies, and its generalizability across different types of RAADs, as well as its druggability, remains to be further validated.
2.Research progress in chemical constituents and pharmacological activities of Inonotus obliquus
Jiamin CUI ; Hairan FAN ; Haimin KUAI ; Xiaolong HU ; Hao WANG
Journal of China Pharmaceutical University 2025;56(4):515-523
As a medicinal and edible fungus, Inonotus obliquus has a long history of folk application in Russia, Japan, and Northeast China. It is rich in terpenoids, steroids, polysaccharides, phenols, alkaloids, etc, and exhibits pharmacological activities including anti-tumor, hypoglycemic, anti-inflammatory, antioxidant, and lipid-lowering effects. Among these, lanostane-type tetracyclic triterpenes represent its characteristic constituents. This review systematically summarizes the research progress on the chemical components isolated and identified from I. obliquus and their pharmacological activities in recent years. The structures of terpenoids, steroids, and phenolic compounds are compiled and illustrated, with a particular focus on the skeletal types and structural characteristics of lanostane-type tetracyclic triterpenes. This work aims to provide some reference for the further investigation and comprehensive development and utilization of I. obliquus.

Result Analysis
Print
Save
E-mail